Rhythm Pharmaceuticals, Inc. (RYTM)
92.83
-0.58
(-0.62%)
USD |
NASDAQ |
Oct 02, 16:00
92.86
+0.02
(+0.03%)
After-Hours: 20:00
Rhythm Pharmaceuticals Price to Book Value : 62.03 for Oct. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 62.03 |
| October 01, 2026 | 62.42 |
| September 30, 2026 | 63.63 |
| September 29, 2026 | 63.96 |
| September 28, 2026 | 65.86 |
| September 25, 2026 | 65.93 |
| September 24, 2026 | 65.69 |
| September 23, 2026 | 65.65 |
| September 22, 2026 | 66.34 |
| September 21, 2026 | 66.04 |
| September 18, 2026 | 65.29 |
| September 17, 2026 | 66.17 |
| September 16, 2026 | 65.49 |
| September 15, 2026 | 64.67 |
| September 14, 2026 | 68.45 |
| September 11, 2026 | 69.97 |
| September 10, 2026 | 68.29 |
| September 09, 2026 | 67.53 |
| September 08, 2026 | 68.03 |
| September 04, 2026 | 68.65 |
| September 03, 2026 | 70.09 |
| September 02, 2026 | 70.45 |
| September 01, 2026 | 69.99 |
| August 31, 2026 | 70.92 |
| August 28, 2026 | 71.61 |
| Date | Value |
|---|---|
| August 27, 2026 | 75.20 |
| August 26, 2026 | 74.76 |
| August 25, 2026 | 75.74 |
| August 24, 2026 | 74.47 |
| August 21, 2026 | 73.51 |
| August 20, 2026 | 72.78 |
| August 19, 2026 | 77.33 |
| August 18, 2026 | 77.01 |
| August 17, 2026 | 77.14 |
| August 14, 2026 | 77.17 |
| August 13, 2026 | 77.53 |
| August 12, 2026 | 78.58 |
| August 11, 2026 | 75.41 |
| August 10, 2026 | 77.17 |
| August 07, 2026 | 77.27 |
| August 06, 2026 | 74.91 |
| August 05, 2026 | 73.98 |
| August 04, 2026 | 70.69 |
| August 03, 2026 | 68.68 |
| July 31, 2026 | 66.32 |
| July 30, 2026 | 70.66 |
| July 29, 2026 | 71.19 |
| July 28, 2026 | 72.20 |
| July 27, 2026 | 70.92 |
| July 24, 2026 | 68.23 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Alnylam Pharmaceuticals, Inc. | 21.70 |
| BioMarin Pharmaceutical, Inc. | 1.750 |
| Cytokinetics, Inc. | -- |
| Exelixis, Inc. | 7.882 |
| Ionis Pharmaceuticals, Inc. | 16.40 |
Price to Book Value Related Metrics
| PS Ratio | 26.09 |
| PEG Ratio | -8.995 |
| Price | 92.83 |
| Earnings Yield | -3.36% |
| Market Cap | 6.388B |
| PEGY Ratio | -8.995 |